DELANZOMIB

UNII:	6IF28942WO
Formula:	C₂₁H₂₈BN₃O₅
Preferred Substance Name:	DELANZOMIB
InChIKey:	SJFBTAPEPRWNKH-CCKFTAQKSA-N

847499-27-8
((1R)-1-(((2S,3R)-3-HYDROXY-2-(((6-PHENYLPYRIDIN-2-YL)CARBONYL)AMINO)-1-OXOBUTYL)AMINO)-3-METHYLBUTYL)BORONIC ACID
((1R)-1-((2S,3R)-3-HYDROXY-2-(6-PHENYLPYRIDINE-2-CARBOXAMIDO)BUTANAMIDO)-3-METHYLBUTYL)BORONIC ACID
B-((1R)-1-((N-((6-PHENYLPYRIDIN-2-YL)CARBONYL)-L-THREONYL)AMINO)-3-METHYLBUTYL)BORONIC ACID
BORONIC ACID, B-((1R)-1-(((2S,3R)-3-HYDROXY-1-OXO-2-(((6-PHENYL-2-PYRIDINYL)CARBONYL)AMINO)BUTYL)AMINO)-3-METHYLBUTYL)-
CEP 18770
CEP-18770
CIP 18770
CIP-18770
CT 47098
CT-47098
DELANZOMIB [INN]
DELANZOMIB [USAN]
DELANZOMIB [WHO-DD]
NPH 007098
NPH007098
NPH-007098

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

DELANZOMIB

Synonyms and Mappings

Resources